• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

液液萃取和离子对高效液相色谱法测定亲水性3-羟基吡啶-4-酮铁螯合剂

Liquid extraction and ion-pair HPLC for determination of hydrophilic 3-hydroxypyridin-4-one iron chelators.

作者信息

Liu D Y, Liu Z D, Lu S L, Hider R C

机构信息

Department of Pharmacy, King's College London, University of London, UK.

出版信息

J Pharm Biomed Anal. 1999 Dec;21(4):759-65. doi: 10.1016/s0731-7085(99)00211-3.

DOI:10.1016/s0731-7085(99)00211-3
PMID:10701941
Abstract

Hydrophilic 3-hydroxypyridin-4-ones (HPOs), such as 1-(2'-carboxyethyl)-2-methyl-3-hydroxypyridin-4-one (CP38), 1-(3'-hydroxypropyl)-2-methyl-3-hydroxypyridin-4-one (CP41) and 1-(2'-hydroxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP102), are orally active iron chelators and ester prodrugs of these molecules are currently under investigation. A liquid extraction method using acetonitrile and 2-propanol (80:20 v/v) under acidic and NaCl-saturated conditions has been developed in order to efficiently extract these HPOs from various matrices. The extracted HPOs were determined using a reversed phase polymer HPLC column (PLRP-S 100 A) and the gradient ion-pair mobile phase containing tetrabutylammonium chloride (5 mM) and EDTA (0.5 mM). The extraction recovery of these chelators in phosphate buffer, rat blood and liver homogenate varied from 85 to 94%. The coefficients of variation (C.V.) for within-day determination were in the range of 1.4-3.3% at 1 mM and 2.0-4.7% at 0.1 mM. High accuracy of determination was also achieved.

摘要

亲水性3-羟基吡啶-4-酮(HPOs),如1-(2'-羧乙基)-2-甲基-3-羟基吡啶-4-酮(CP38)、1-(3'-羟丙基)-2-甲基-3-羟基吡啶-4-酮(CP41)和1-(2'-羟乙基)-2-乙基-3-羟基吡啶-4-酮(CP102),是口服活性铁螯合剂,目前正在研究这些分子的酯前药。已开发出一种在酸性和NaCl饱和条件下使用乙腈和2-丙醇(80:20 v/v)的液液萃取方法,以便从各种基质中有效萃取这些HPOs。使用反相聚合物HPLC柱(PLRP-S 100 A)和含有四丁基氯化铵(5 mM)和EDTA(0.5 mM)的梯度离子对流动相测定萃取的HPOs。这些螯合剂在磷酸盐缓冲液、大鼠血液和肝脏匀浆中的萃取回收率在85%至94%之间。日内测定的变异系数(C.V.)在1 mM时为1.4 - 3.3%,在0.1 mM时为2.0 - 4.7%。测定也具有很高的准确性。

相似文献

1
Liquid extraction and ion-pair HPLC for determination of hydrophilic 3-hydroxypyridin-4-one iron chelators.液液萃取和离子对高效液相色谱法测定亲水性3-羟基吡啶-4-酮铁螯合剂
J Pharm Biomed Anal. 1999 Dec;21(4):759-65. doi: 10.1016/s0731-7085(99)00211-3.
2
Gradient ion-pair high-performance liquid chromatographic method for analysis of 3-hydroxypyridin-4-one iron chelators.用于分析3-羟基吡啶-4-酮铁螯合剂的梯度离子对高效液相色谱法
J Chromatogr B Biomed Sci Appl. 1999 Jun 25;730(1):135-9. doi: 10.1016/s0378-4347(99)00198-x.
3
Hydrolytic and metabolic characteristics of the esters of 1-(3'-hydroxypropyl)-2-methyl-3-hydroxypyridin-4-one (CP41), potentially useful iron chelators.
Pharmacol Toxicol. 2000 May;86(5):228-33. doi: 10.1034/j.1600-0773.2000.d01-40.x.
4
Design, synthesis, and biological evaluation of aromatic ester prodrugs of 1-(3'-hydroxypropyl)-2-methyl-3-hydroxypyridin-4-one (CP41) as orally active iron chelators.1-(3'-羟丙基)-2-甲基-3-羟基吡啶-4-酮(CP41)的芳香酯前药作为口服活性铁螯合剂的设计、合成及生物学评价
Arzneimittelforschung. 2000 May;50(5):461-70. doi: 10.1055/s-0031-1300231.
5
Synthesis, physicochemical properties and biological evaluation of aromatic ester prodrugs of 1-(2'-hydroxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP102): orally active iron chelators with clinical potential.1-(2'-羟乙基)-2-乙基-3-羟基吡啶-4-酮(CP102)的芳香酯前药的合成、理化性质及生物学评价:具有临床潜力的口服活性铁螯合剂
J Pharm Pharmacol. 1999 May;51(5):555-64. doi: 10.1211/0022357991772655.
6
Metabolism and pharmacokinetics of 1-(2'-hydroxy-ethyl)- and 1-(3'-hydroxypropyl)-2-ethyl-3-hydroxypyridin-4-ones in the rat.1-(2'-羟乙基)-和1-(3'-羟丙基)-2-乙基-3-羟基吡啶-4-酮在大鼠体内的代谢及药代动力学
Eur J Drug Metab Pharmacokinet. 1996 Jan-Mar;21(1):33-41. doi: 10.1007/BF03190276.
7
Novel orally active iron chelators (3-hydroxypyridin-4-ones) enhance the biliary excretion of plasma non-transferrin-bound iron in rats.
J Hepatol. 1997 Jul;27(1):176-84. doi: 10.1016/s0168-8278(97)80299-1.
8
Synthesis, physicochemical characterization, and biological evaluation of 2-(1'-hydroxyalkyl)-3-hydroxypyridin-4-ones: novel iron chelators with enhanced pFe(3+) values.2-(1'-羟烷基)-3-羟基吡啶-4-酮的合成、理化性质表征及生物学评价:具有提高的pFe(3+)值的新型铁螯合剂
J Med Chem. 1999 Nov 18;42(23):4814-23. doi: 10.1021/jm991080o.
9
Development and validation of HPLC-DAD methods for the analysis of two novel iron chelators with potent anti-cancer activity.
J Pharm Biomed Anal. 2007 Mar 12;43(4):1343-51. doi: 10.1016/j.jpba.2006.11.011. Epub 2006 Dec 12.
10
Determination of a new oral iron chelator, ICL670, and its iron complex in plasma by high-performance liquid chromatography and ultraviolet detection.采用高效液相色谱法和紫外检测法测定新型口服铁螯合剂ICL670及其血浆中的铁络合物。
J Chromatogr B Biomed Sci Appl. 2001 May 5;755(1-2):203-13. doi: 10.1016/s0378-4347(01)00079-2.